1. Home /
  2. Pharmaceuticals

Pharmaceuticals

Lannett to Be U.S. Distributor of Posaconazole Delayed-Release Tablets

Lannett to Be U.S. Distributor of Posaconazole Delayed-Release Tablets

The company will be the exclusive U.S. distributor of fungal disease medication Posaconazole delayed-release tablets.

Purdue Pharma Reportedly Offers $10 Billion to $12 Billion for Opioid Settlements

Purdue Pharma Reportedly Offers $10 Billion to $12 Billion for Opioid Settlements

Purdue Pharma is offering to settle more than 2,000 lawsuits related to the opioid crisis, NBC reports.

These Drug Cos. Could Soon Feel Big Side Effects of Opioid Crisis

These Drug Cos. Could Soon Feel Big Side Effects of Opioid Crisis

No company is safe from the litigation risk tied to the drug epidemic, but Johnson & Johnson may be one of the few guaranteed to survive.

Johnson & Johnson's Fine May Be the Pin Prick That Keeps Bleeding

Johnson & Johnson's Fine May Be the Pin Prick That Keeps Bleeding

By failing to settle like Purdue Pharma, JNJ is taking a risky gamble that could open itself up to many more state court battles and penalties.

Johnson & Johnson Rises on $572 Million Fine That's Smaller Than Feared

Johnson & Johnson Rises on $572 Million Fine That's Smaller Than Feared

Wall Street expects the healthcare giant can take the jolt from the penalty delivered by an Oklahoma judge in the state's opioid case against J&J.

Johnson & Johnson Is in the News, but How Do the Charts Look?

Johnson & Johnson Is in the News, but How Do the Charts Look?

I am not focused on today's price movement of the stock but the pattern from the end of 2017.

J&J Ordered to Pay $572 Million in Oklahoma Opioid Case

J&J Ordered to Pay $572 Million in Oklahoma Opioid Case

J&J said it would appeal the judge's decision. The judgment was less than Wall Street was expecting. The stock rose after hours.

How Abbott Is Celebrating Women in STEM on Women's Equality Day

How Abbott Is Celebrating Women in STEM on Women's Equality Day

Here's how to empower the next generation of women going into STEM.

How Reinventing the Lab Coat Can Empower the Minds of Tomorrow

How Reinventing the Lab Coat Can Empower the Minds of Tomorrow

Here's how a project--such as reinventing the lab coat--can empower the minds of tomorrow.

Medicines Co. Rises on Positive Phase 3 Trial for Cholesterol Lowering Therapy

Medicines Co. Rises on Positive Phase 3 Trial for Cholesterol Lowering Therapy

The biopharmaceutical company reports positive Phase 3 trial results for its cholesterol-lowering therapy inclisiran.